Literature DB >> 35486077

CXCL10 and Soluble Programmed Death-Ligand 1 during Respiratory Viral Infections Are Associated with Chronic Lung Allograft Dysfunction in Lung Transplant Recipients.

Eric D Morrell1,2,3, Carolyn Brager1, Kathleen J Ramos1, Xin-Ya Chai1, Siddhartha G Kapnadak1, Jeffrey Edelman1,2, Gustavo Matute-Bello1,2,3, William A Altemeier1,3, Billanna Hwang1,3, Michael S Mulligan1,3, Pavan K Bhatraju1, Mark M Wurfel1,3, Carmen Mikacenic4, Erika D Lease1, Ajit P Limaye1, Cynthia E Fisher1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35486077      PMCID： PMC9116355          DOI： 10.1165/rcmb.2021-0404LE

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN： 1044-1549            Impact factor:   6.914


× No keyword cloud information.
  16 in total

1.  Constitutive and inducible expression of b7 family of ligands by human airway epithelial cells.

Authors:  Jean Kim; Allen C Myers; Lieping Chen; Drew M Pardoll; Quynh-Ai Truong-Tran; Andrew P Lane; John F McDyer; Lowella Fortuno; Robert P Schleimer
Journal:  Am J Respir Cell Mol Biol       Date:  2005-06-16       Impact factor: 6.914

2.  Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT.

Authors:  Geert M Verleden; Allan R Glanville; Erika D Lease; Andrew J Fisher; Fiorella Calabrese; Paul A Corris; Christopher R Ensor; Jens Gottlieb; Ramsey R Hachem; Vibha Lama; Tereza Martinu; Desley A H Neil; Lianne G Singer; Greg Snell; Robin Vos
Journal:  J Heart Lung Transplant       Date:  2019-04-03       Impact factor: 10.247

Review 3.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: Definition and grading-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation.

Authors:  Gregory I Snell; Roger D Yusen; David Weill; Martin Strueber; Edward Garrity; Anna Reed; Andres Pelaez; Timothy P Whelan; Michael Perch; Remzi Bag; Marie Budev; Paul A Corris; Maria M Crespo; Chad Witt; Edward Cantu; Jason D Christie
Journal:  J Heart Lung Transplant       Date:  2017-07-26       Impact factor: 10.247

4.  High circulating CD4+CD25hiFOXP3+ T-cell sub-population early after lung transplantation is associated with development of bronchiolitis obliterans syndrome.

Authors:  Maxim Durand; Philippe Lacoste; Richard Danger; Lola Jacquemont; Carole Brosseau; Eugénie Durand; Gaelle Tilly; Jennifer Loy; Aurore Foureau; Pierre-Joseph Royer; Adrien Tissot; Antoine Roux; Martine Reynaud-Gaubert; Romain Kessler; Sacha Mussot; Claire Dromer; Olivier Brugière; Jean François Mornex; Romain Guillemain; Johanna Claustre; Nicolas Degauque; Antoine Magnan; Sophie Brouard
Journal:  J Heart Lung Transplant       Date:  2018-03-20       Impact factor: 10.247

5.  Respiratory viruses and chronic rejection in lung transplant recipients.

Authors:  Joanne L Billings; Marshall I Hertz; Kay Savik; Christine H Wendt
Journal:  J Heart Lung Transplant       Date:  2002-05       Impact factor: 10.247

6.  Graft Loss and CLAD-Onset Is Hastened by Viral Pneumonia After Lung Transplantation.

Authors:  Paul R Allyn; Erin L Duffy; Romney M Humphries; Patil Injean; S Samuel Weigt; Rajan Saggar; Michael Y Shino; Joseph P Lynch; Abbas Ardehali; Bernard Kubak; Chi-Hong Tseng; John A Belperio; David J Ross; Aric L Gregson
Journal:  Transplantation       Date:  2016-11       Impact factor: 4.939

7.  Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.

Authors:  Susan Stewart; Michael C Fishbein; Gregory I Snell; Gerald J Berry; Annette Boehler; Margaret M Burke; Alan Glanville; F Kate Gould; Cynthia Magro; Charles C Marboe; Keith D McNeil; Elaine F Reed; Nancy L Reinsmoen; John P Scott; Sean M Studer; Henry D Tazelaar; John L Wallwork; Glen Westall; Martin R Zamora; Adriana Zeevi; Samuel A Yousem
Journal:  J Heart Lung Transplant       Date:  2007-12       Impact factor: 10.247

8.  Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer.

Authors:  Bo Gong; Kazuma Kiyotani; Seiji Sakata; Seiji Nagano; Shun Kumehara; Satoko Baba; Benjamin Besse; Noriko Yanagitani; Luc Friboulet; Makoto Nishio; Kengo Takeuchi; Hiroshi Kawamoto; Naoya Fujita; Ryohei Katayama
Journal:  J Exp Med       Date:  2019-03-14       Impact factor: 14.307

9.  Symptomatic Respiratory Virus Infection and Chronic Lung Allograft Dysfunction.

Authors:  Cynthia E Fisher; Carl M Preiksaitis; Erika D Lease; Jeffrey Edelman; Katharine A Kirby; Wendy M Leisenring; Ganesh Raghu; Michael Boeckh; Ajit P Limaye
Journal:  Clin Infect Dis       Date:  2015-11-12       Impact factor: 9.079

10.  Viral Respiratory Tract Infection During the First Postoperative Year Is a Risk Factor for Chronic Rejection After Lung Transplantation.

Authors:  Jesper Magnusson; Johan Westin; Lars-Magnus Andersson; Magnus Lindh; Robin Brittain-Long; Rickard Nordén; Gerdt C Riise
Journal:  Transplant Direct       Date:  2018-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.